As a nurse practitioner working in thoracic medical oncology, I have seen the changes in non-small cell lung cancer (NSCLC) change dramatically over the past 20 years that I have been practicing in this subspecialized field. Twenty years ago were the days of just paclitaxel and carboplatin as ...
Starting physician assistant (PA) school certainly presented its obstacles. How would I, a fresh college graduate, be able to tackle an intense medical education within the span of 27 months? The answer was almost too simple – one semester at a time. Fifteen months of didactic education came and ...
Chronic graft-versus-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up to 70% of patients, cGVHD is the leading cause of non-relapse mortality after allogeneic transplantation. Two new agents, belumosudil ...
Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal syndrome characterized by unchecked and persistent activation of cytotoxic T-cells and natural killer (NK) cells (Al-Samkari, Berliner, 2018). This uncontrolled immune response leads to increased secretion of inflammatory ...
Administrators, managers, and even clinicians have often used the terms “coding” and “billing” interchangeably. However, these terms in fact refer to separate pieces of the health care administrative structure. Services, the actual assistance or guidance provided to the patient, are matched to a ...
Non-small cell lung cancer (NSCLC) is the third most common type of cancer in the Unites States (US). It is known to harbor many types of mutations, making it particularly difficult to define the best treatment algorithm for a patient, especially after first line treatment. Over the last few ...
Chimeric antigen receptor T (CAR-T) therapies have resulted in durable remissions for patients with refractory hematologic malignancies; however, patients can experience many side effects following administration. Cytokine release syndrome (CRS) occurs as a result of rapid immune activation induced ...
A thorough assessment of the patient with a hematologic malignancy is essential for the delivery of quality care. Almost every medical condition, symptom or complication will be caused by the patient’s underlying disease, a medication they have been prescribed, or an infection. Taking time to ...
In 2021, the American Cancer Society (ACS) reported a substantial decrease in cancer-related mortality in the United States. This data represents incidence and mortality rates through the 2017-2018 years. The ACS report for 2021 reported a record 2.4% decline in cancer mortality from 2017-2018, ...
Since the 2006 publication of From Cancer Patient to Cancer Survivors: Lost in Transition by the Institute of Medicine (IOM) on cancer survivorship, improvements have been made in the care of survivors. According to the report, cancer survivors were “lost in transition” and primary care providers ...
Beth Sandy, MSN, CRNP
Read more
Rory Medley, PA-S
.jpg?width=40&name=Untitled%20design%20(2).jpg){kind=avatar}
Ila M. Saunders, PharmD, BCOP & Fatima Khan, PharmD
Elizabeth S. Waxman, BSN, RN, MSN, ANP-BC
Bo Gamble
-1.jpg?width=40&name=Untitled%20design%20(1)-1.jpg){kind=avatar}
Tori Gray, PharmD Candidate & Megan B May, PharmD, BCOP
Abigail Shockley, PharmD
Glen J Peterson, RN, DNP, ACNP & Jessica Casselberry, MSN, ANP-BC, AOCNP
Ellen Mullen RN, PhD, GNP-BC, ANP-C